Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SyB L-0501 + Rituximab in Untreated Low-grade B-cell NHL and MCL
NCT01718691Phase 2Completed
- Sponsor
- SymBio Pharmaceuticals
- Start
- Nov 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in non-Hodgkin lymphoma (NHL), Mantle cell lymphoma (MCL), sponsored by SymBio Pharmaceuticals. Started Nov 2011; status: completed.
02
Drugs
bendamustine
03
Conditions
non-Hodgkin lymphoma (NHL)Mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01718691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718691.